Clinical characteristics of patients with various genetic types of long QT syndrome

The aim of the study is to evaluate clinical characteristics, including adverse events and outcomes, in patients with various genetic types of long QT syndrome (LQTS).

Material and methods. We examined 24 patients with a clinical diagnosis of LQTS, observed in the for 5 years. The clinical and instrumental study included registration of electrocardiography (ECG), Holter monitoring, collection of a genealogical history with an ECG assessment of all family members and identification of cases of sudden cardiac death (SCD) in the family or the presence of a family form of the disease, echocardiography and cardiac magnetic resonance imaging to exclude structural changes in the myocardium. The search for mutations in the coding sequences of genes associated with the development of channelopathy and other hereditary heart rhythm disorders was carried out by next generation sequencing (NGS).

Results. Mutations in 4 genes associated with LQTS (KCNQ1, KCNH2, CACNA1C, ANK2) were detected in 18 out of 24 (75.0%) patients. Mutations in the KCNQ1, KCNH2 and CACNA1C genes were detected in 14 (58.0%) patients. In 4 out of 24 (17%) patients, two or more variants of clinical significance (VUS) were detected in the genes associated with LQTS and hereditary arrhythmias, 6 patients had no genetic changes. The most severe form of the disease with pronounced clinical manifestations and episodes of clinical death with subsequent resuscitation measures, as well as a significant increase in the QTc interval exceeding 500 ms, was observed in patients with LQT2 and multiple mutations. Implantation of a cardioverter-defibrillator (CD) was required in 14 (58.3%) patients, including 11 (78.56%) - for secondary prevention of SCD and 3 (21.4%) - for primary prevention.

Conclusion. A comparative analysis between different genetic types of LQTS (LQT1; LQT2; patients with multiple VUS) showed that in patients with LQT1 syndrome, despite the early manifestation of the disease and the presence of syncopal conditions, life-threatening arrhythmias, SCD and the frequency of CD implantation were significantly less often recorded than in other LQTS. The most severe form of the disease with pronounced clinical manifestations, episodes of clinical death with subsequent resuscitation and CD implantation was observed both in the group of probands with LQT2 and in patients with several nucleotide variants (VUS), one of which was in the CACNA1C or ANK2 genes. 

1. Schwartz PJ, Crotti L, Insolia R. Long QT syndrome: from genetics to management. Circ Arrhythm Electroophysiol. 2012;5(4): 868-77. https://doi.org/10.1161/CIRCEP.111.962019.

2. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18): 1761-7. https://doi.org/10.1161/CIRCULATIONAHA.109.863209.

3. Adler A, Novelli V, Amin AS, et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long-QT syndrome. Circulation. 2020;141(6): 418-28. https://doi.org/10.1161/CIRCULATIONAHA.119.043132.

4. Zhang L, Timothy KW, Vincent CM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102(23): 2849-55. https://doi.org/10.1161/01.cir.102.23.2849.

5. Schwartz PJ, Ackerman MJ, Antzelevitch C, et al. Inherited cardiac arrhythmias. Nat Rev Dis Primers. 2020;6(1): 58. https://doi.org/10.1038/s41572-020-0188-7.

6. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8(8): 1308-39. https://doi.org/10.1016/j.hrthm.2011.05.020.

7. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003; 348(19): 1866-74. https://doi.org/10.1056/NEJMoa 022147.

8. Priori S, Napolitano C. Genetics of channelopathies and clinical implications. In. Fuster V, Walsh R, Harrington R, eds. Hurstꞌs the Heart. 13th ed. New York 2011: 897-910.

9. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1): 89-95. https://doi.org/10.1161/01.cir.103.1.89.

10. Schwartz PJ, Vanoli E, Crotti L, et al. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J Am Coll Cardiol. 2008;51(9): 920-9. https://doi. org/10.1016/j.jacc.2007.09.069.

11. Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA. 2004;292(11): 1341-4. https://doi.org/10.1001/jama.292.11.1341.

12. Vincent GM, Schwartz PJ, Denjoy I, et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. Circulation. 2009;119(2): 215-21. https://doi.org/10.1161/CIRCULATIONAHA.108.772533.

13. Taggart NW, Haglund CM, Tester DJ, et al. Diagnostic miscues in congenital long-QT syndrome. Circulation. 2007;115(20): 2613-20. https://doi.org/10.1161/CIRCULATIONAHA.106.661082.

14. Schwartz PJ, Grotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124(20): 2181-4. https://doi.org/10.1161/CIRCULATIONAHA.111.062182.

15. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16): e164. https://doi.org/10.1093/nar/gkq603

16. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the Association for molecular pathology. Genet Med. 2015;17(5): 405-23. https://doi.org/10.1038/gim.2015.30

17. Chakova NN, Komissarova SM, Niyazova SS, et al. Multiple mutations in associated with LQTS genes in patients with life-threating ventricular tachyarrhythmias. Medical Genetics. 2020;19(12): 47-55. (In Russ.).

18. Mullally J, Goldenberg I, Moss AJ, et al. Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations. Hearth Rhythm. 2013;10(3): 378-82. https://di.org/10.1016/j.hrthm.2012.11.006.